Compare Davita Inc (DVA) vs Innovative Industrial Properties Inc (IIPR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs Innovative Industrial Properties Inc — how do they compare? Davita Inc trades at $179.97 (market cap $11.38B), while Innovative Industrial Properties Inc trades at $57.75 (market cap $1.67B). The key difference: Davita Inc is far larger — about 6.8× Innovative Industrial Properties Inc's market cap, and Innovative Industrial Properties Inc pays a 13.18% dividend while Davita Inc pays none. Which is the better fit depends on your goals.
| DVA | IIPR | |
|---|---|---|
Market Cap | $11.38B | $1.67B |
Sector | Health | Real Estate |
52-Week High | $240.96 | $64.67 |
52-Week Low | $103.87 | $44.58 |
Enterprise Value | $24.10B | $2.21B |
Dividend Yield | — | 13.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $180.25, down 1.87% amid mixed signals. The stock shows strong earnings momentum with three consecutive quarterly beats (Q4 2025-Q2 2026) but faces margin pressure. Technical indicators are conflicted with a bullish overall signal but bearish moving averages. Revenue growth remains steady, climbing from $11.6B in 2022 to $13.6B in 2025, though net income margin fluctuated between 4.82% and 7.3% over the same period.
The outlook is cautiously optimistic with a $232.25 consensus price target offering 29% upside. Key risks include reimbursement pressure and high debt levels (debt-to-asset ratio of 65.55% in 2025). Analyst sentiment leans neutral (56.52% Hold) despite recent earnings strength, reflecting concerns about payer mix and margin sustainability.
Innovative Industrial Properties (IIPR) trades at $57.84, up 0.63% on the day, with a bearish technical signal and neutral oscillators. The company reported Q2 2026 revenue of $63.3 million and FFO of $1.83 per share, beating estimates. Financials show strong gross margins of 88.35% but declining revenue from $266 million in 2025 to $264 million in 2026. Recent news highlights institutional buying and dividend sustainability debates amid tenant distress concerns.
Outlook remains mixed with a discounted P/E of 13.05 and high dividend yield offering value, but risks include revenue contraction, tenant diversification issues, and bearish technical trends. Analyst consensus is cautious with 36% buy ratings. The stock presents income appeal but requires monitoring of operational execution and cannabis sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About Innovative Industrial Properties Inc
Innovative Industrial Properties Inc is a real estate investment trust engaged in the acquisition, ownership, and management of specialized industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities. It conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by Operating Partnership, directly or through subsidiaries. Its property portfolio is spread across the United States.
Read more on IIPR →
